Pharmaceutical compositions

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Crystal forms of demethyleneberberine hydrochloride and preparation method therefor

Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone

Crystalline forms and compositions of CFTR modulators

SULFASALAZINE SALT COMPOSITIONS AND METHODS OF USING THE SAME

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

SALT OF FUSED HETEROCYCLIC DERIVATIVE AND CRYSTAL THEREOF

Method for producing antibody-drug conjugate

Compound functioning as bromodomain protein inhibitor, and composition

Crystalline forms of cabotegravir sodium

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof

Tertiary alcohols as PI3K-γ inhibitors

Crystal form of β-lactamase inhibitor and preparation method therefor

Pyrroloquinoline quinone glycine betaine salt

Crystal form of oxopicolinamide derivative and preparation method therefor

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

Cocrystals of ubiquinol and compositions comprising them

Process for THR preparation of natural crystallized thymol from (Jammu Monarda) oil

Polymorphic forms of Dasatinib

Inhibitors

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

Inhibitors of APOL1 and methods of using same

Octendidine based compounds

Solid forms comprising an oxime ether compound, compositions and methods of use thereof

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Inhalable imatinib formulations, manufacture, and uses thereof

Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH

Process for the preparation of 3α,7α-dihydroxy-6α-ethyl-5β-cholan-24-oic acid

Salt of pyranose-substituted heterocyclic compound, preparation method therefor and use thereof

Solid state forms

Pyrimidine compound as JAK kinase inhibitor

Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole

Crystal form of urate transporter 1 inhibitor and preparation method and use thereof

Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione

Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione

Chiral 1,3-diarylimidazolium salt carbene precursor, synthesis method therefor, metal salt compound and application thereof

Crystalline forms

Cocrystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-l,3-diol

Use of TG02 for treating gliomas in pediatric subjects

Atmospheric moisture harvester

Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof

Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule comprising NK1 and NK3 receptors antagonists

Method of treatment of symptoms of menopause

Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof

Polymorphism for irinotecan free base

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Modulators of alpha-1 antitrypsin

PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME

Polymorphs

DEUTERATED INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION THEREOF

Crystal form of URAT1 inhibitor, and preparation method therefor

SOLID STATE FORM OF PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE

EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application

CRYSTALS OF ANILINE PYRIMIDINE COMPOUND SERVING AS EGFR INHIBITOR

Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

Crystal form I of a 5-aminopyrazole carboxamide compound as BTK inhibitor

Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making

Method for producing crystal of uracil compound

Sulfonamide Compounds and Use Thereof

Process for the preparation of diphenylpyrazine derivatives

COMPOUNDS

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1Preceptor-associated disorders

25-hydroxycholecalciferol monohydrate crystal, preparation method therefor and microemulsion using same

Polymorphic forms of RAD1901-2HCL

Inhalable imatinib formulations, manufacture, and uses thereof

Inhalable imatinib formulations, manufacture, and uses thereof

Sulfasalazine salts, production processes and uses

USE OF CO-CRYSTALS OF TRAMADOL AND CELECOXIB FOR TREATING PAIN WHILE REDUCING THE ABUSE LIABILITY OF TRAMADOL

Inhalable imatinib formulations, manufacture, and uses thereof

Coordinative alignment of molecules in chiral metal-organic frameworks

Crystalline linagliptin intermediate and process for preparation of linagliptin

Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypryridin-2-YL)benzoic acid

Solid state forms of venetoclax and its process for the preparation there of

Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate

Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of Manufacturing Cannabidiol or Cannabidivarin

Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

De novo design of potent and selective interleukin mimetics

Co-crystal forms of a novobiocin analog and proline

Crystal form of acalabrutinib and preparation method and use thereof

Salts of TAM inhibitors

Process for the preparation of umeclidinium bromide

Solid forms of a toll-like receptor modulator

Solid state form of Valbenazine

Crystal form of indole derivative and preparation method and use thereof

CRYSTAL FORM OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL INHIBITOR AND PREPARATION METHOD THEREOF

SOLID FORMS OF AN HIV PROTEASE INHIBITOR

Compound having cyclic structure

Crystalline forms of lenalidomide

Solid forms of a toll-like receptor modulator

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Crystalline forms of compounds for preventing or treating sensory hair cell death

Dosage forms comprising a plasma kallikrein inhibitor

De novo design of potent and selective interleukin mimetics

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

Polymorphs of Ribociclib mono succinate

CRYSTALLINE SUBSTITUTED CYCLOHEXYL PYRAZOLO[1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUND AND THERAPEUTIC USES THEREOF

Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile

Valbenazine salts and polymorphs thereof

Valbenazine salts and polymorphs thereof

Valbenazine salts and polymorphs thereof

Crystal and salt forms of tricyclic compound and preparation process thereof

Crystalline form of ozanimod hydrochloride, and processes for preparation thereof

Crystalline forms of mesaconine and preparation methods therefor

Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof

Formulations comprising heterocyclic protein kinase inhibitors

Bromodomain inhibitor

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Processes for the preparation of SGLT-2 inhibitors, intermediates thereof

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one

Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio

Process for the preparation of rucaparib and novel synthesis intermediates

Process for preparing large size isoxazoline particles

Solid state forms of eltrombopag choline

Salts and polymorphs of a PDE4 inhibitor

CO-CRYSTAL OF TOCOPHEROL AND PROLINE AND PREPARATION METHOD THEREOF

Two-dimensional coordination polymers

Method for preparing a limax compound and therapeutic use thereof

Crystalline forms of lorlatinib maleate

Treatment of osteoarthritis

Crystalline salt forms of 3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide for medical application

Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ErbB receptor inhibitors

Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl) benzoic acid

Synthesis of antibacterial aminoglycoside analogs

Crystalline forms of a biphenyl compound

POLYMORPHS OF N-[(2,6-DIFLUORO-3-METHOXYPHENYL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE

Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors

POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF

Crystalline Form of Betrixaban Maleate

Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal

Crystalline form of lorlatinib free base hydrate

Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof

Co-crystals of neflamapimod (VX-745)

Solid state forms of Ivosidenib

SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF

Crystals of tetrahydronaphthyl urea derivative

Edaravone salt

Crystalline salts of a plasma kallikrein inhibitor

Crystalline freebase forms of a biphenyl compound

Crystalline forms

NOVEL METHOD FOR PRODUCING HYDROXAMIC ACID DERIVATIVE, AND INTERMEDIATE THEREFOR

NOVEL CRYSTALS OF HYDROXAMIC ACID DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION

Process for the preparation of lifitegrast

Crystalline form of obeticholic acid and preparation method therefor

Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase

SOLID FORMS OF A COMPOUND FOR MODULATING KINASES

Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof

FURAN SKELETON-CONTAINING IMINOGUANIDINE DERIVATIVE AS WELL AS PREPARATION AND APPLICATION THEREOF

Crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and method for preparing same

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Polymorph of rucaparib camsylate

Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors

Crystal form of PARP-1 inhibitor and preparation method therefor

Crystalline form of an avibactam derivative

Crystalline sulfamide compound

Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof

Process for preparation of Siponimod, its salts and solid state forms thereof

Chlorhexidine crystal forms and uses thereof in medicine

METHOD OF THE ISOLATING CHLOROSESAMONE OR CHLOROSESAMONE-CONTAINING FRACTION FROM ROOTS OF GENUS SESAMUM, AND APPLICATION OF THE FRACTION THEREOF

Novel Pyrazolo Pyrimidine Derivatives

Formulation for parenteral administration

Crystalline dipeptides useful in the synthesis of elamipretide

Solid forms of an antiviral compound

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Crystalline solid forms of a BET inhibitor

Crystalline salts of a B-RAF kinase inhibitor

Polymorphs of selinexor

Process for preparing crystalline Tipiracil Hydrochloride

Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride and their processes for the preparation thereof

KDM1A inhibitors for the treatment of disease

Processes for preparing ASK1 inhibitors

SOLID STATE FORMS OF ELAFIBRANOR

Crystalline Form of y-Aminobutyric Acid Analog

Extract effective in treating drug addiction

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

ARAMCHOL SALTS

Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof

Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same

Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same

Oriented perovskite crystals and methods of making the same

POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS

Process for the preparation of ribociclib and its salts

Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl) methyl sulfamate, formulations and uses thereof

Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors

Plinabulin compositions

Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide

SOLID STATE FORMS OF TRISODIUM VALSARTAN: SACUBITRIL

Crystalline forms of hydrochloride salts of thienopyrimidine compound

Solid forms of TTK inhibitor

Solid polymorphs of a FLNA-binding compound and its hydrochloride salts

Crystalline forms of a FGFR inhibitor and processes for preparing the same

CRYSTALLINE FORMS OF ARN-509, PREPARATION METHOD AND USE THEREOF

Crystalline forms of ()-afoxolaner

Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof

Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol

Method for producing aldehyde and method for producing alcohol

LULICONAZOLE AS ANTI-ACANTHAMOEBA AGENT AND METHOD FOR PRODUCING THE SAME

Methods of treating Parkinson's disease

Polymorphic form of TG02 for treating cancer

Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof

Compounds, compositions and methods for treatment of eye disorders and skin diseases

Co-crystal of an orally available HIF prolyl hydroxylase inhibitor

Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D

Salts and crystal forms of GABApositive allosteric modulator

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Crystal of tricyclic compound

NOVEL SALTS

Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate

Crystalline form E1 of larotrectinib ethanesulfonate

Methods for the treatment of gastro-intestinal disorders

FXR (NR1H4) modulating compounds

Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone

Rotigotine behenate, and manufacturing method and application thereof

Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis

Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n- benzylacetamide

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR

Stereoselective process for preparing substituted polycyclic pyridone derivatives

Salts and crystals

Pyrimidine compound, chloride salt thereof, and manufacturing and application of same

Troxacitabine synthesis and crystal form thereof

Co-crystal and/or eutectic crystal of kojic acid, compositions comprising the same, process of producing the same, and uses thereof

Crystal forms of immunomodulators

Processes for preparing AG-10, its intermediates, and salts thereof

Polymorphs and co-crystals of roxadustat

Crystal form of estrogen receptor inhibitor and preparation method therefor

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Solid forms of substituted benzoxaborole and compositions thereof

Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

Inhibiting agents for Bruton's tyrosine kinase

Crystal forms of an androgen receptor antagonist, preparation method and use thereof

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-peridine-2,6-dione

Crystalline forms of 3-substituted 1,2,4-oxadiazole

Sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide

ORALLY ADMINISTRABLE MODIFIED-RELEASED PHARMACEUTICAL DOSAGE FORM

Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof

CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR

Polymorps of cariprazine hydrochloride and preparation method thereof and use of same

Polymorphs of 5-fluoro-4-imino-3-methyl-1 -tosyl-3,4-dihydropyrimidin-2-one

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS

Crystalline forms of a brutons tyrosine kinase inhibitor

PKC inhibitor solid state forms

Phenoxyquinazoline compounds and their use in treating cancer

Crystals

Crystalline substituted pyrazines as PGI2 receptor agonists

Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

Formulations of pimavanserin

Highly purified recombinant human insulin (RHI) API and methods of producing the same

Method of manufacturing a pharmaceutical composition

Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof

DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES

Crystalline forms of therapeutic compounds and uses thereof

Crystalline forms of therapeutic compounds and uses thereof

Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof

Crystal form and salt form of -phenyl-2-aminopyrimidine compound, and preparation method therefor

Production method of thiazole derivative

SOLID STATE FORMS OF ENTRECTINIB

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof

Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same

Dexrabeprazole sodium compound and pharmaceutical composition thereof

Crystalline polymorph of Ponesimod

Crystalline forms of ozanimod and processes for preparation thereof

Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

Crystalline forms of beta-sitosterol

Method For Preparing Heterocyclic Derivative Compound, Composition Containing Same Compound, And Hydrate of Same Compound

Crystal form II of thienopyridine derivative bisulfate and preparation method therefor and use thereof

Crystalline form of Valbenazine dibesylate

A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF

Methods for making and using endoxifen

COMBINED MEDICINAL PREPARATION FOR TREATING VIRAL INFECTIONS

Compounds

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Processes for preparing ACC inhibitors and solid forms thereof

Compound and preparation method thereof

Solid forms of acalabrutinib and process for preparation thereof

Solid state forms of palbociclib dimesylate

Crystalline form of a BACE inhibitor, compositions, and use

Novel Polymorphic Forms of a TGFBeta Inhibitor

Crystalline eravacycline bis-hydrochloride

Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Salts of selective estrogen receptor degraders

Functional crystalline sweetener

Crystalline solvate forms of a pharmaceutical

Inclusion complexes of an HCV NS5B inhibitor and uses thereof